Hotez says that unlike the mRNA vaccines from Pfizer and Moderna, and the viral vector vaccine from Johnson & Johnson, protein subunit vaccines like CORBEVAX have a track record. So he and Bottazzi were relatively certain CORBEVAX would be safe and effective. "And it's cheap, a dollar, dollar fifty a dose," Hotez says. "You're not going to get less expensive than that." [More]
Possibly. But the objective of the game they have entered is to destroy the other players.
[Via Jess]
"This involves using proteins from a virus or bacterium that can induce an immune response but not cause disease."
ReplyDeleteI wish the NPR "journalist" had taken the time to explain how this significantly differs from the current vaccines that introduce "spike proteins that can induce an immune response but not cause disease."
Perhaps they just believe that the average NPR listener is too stupid to benefit from such a discussion.
The one problem with this as to why the people will never see this vaccine in (cough, cough) "first world" countries........Will Fauci, or any others in his circle, profit from it? No? Then it will never see the light of day for us. Simple as that.
ReplyDelete